Bristol-Myers Squibb Company (BMY) SVP Sells $560400.00 in Stock

The institutional investor held 173,013 shares of the electromedical & electrotherapeutic apparatus company at the end of 2016Q4, valued at $12.32M, up from 122,019 at the end of the previous reported quarter. Versartis now has $710.80 million valuation. Fagan Inc reported 8,195 shares. It has outperformed by 45.78% the S&P500. Tradewinds Capital Management LLC increased its stake in Bristol-Myers Squibb by 34.6% during the 2nd quarter. Smith Moore & Company acquired 5,905 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The institutional investor held 19,550 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $1.14 million, down from 109,060 at the end of the previous reported quarter. Bristol Myers Squibb Co now has $102.69 billion valuation. It closed at $62.62 lastly. Apple Inc. (NASDAQ:AAPL) has risen 62.48% since September 11, 2016 and is uptrending. It has underperformed by 39.89% the S&P500. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have assigned a buy rating to the company. Therefore 32% are positive. Bristol-Myers Squibb Company has a 52 week low of $46.01 and a 52 week high of $63.47. Deutsche Bank maintained the stock with “Hold” rating in Friday, October 28 report. The rating was maintained by Deutsche Bank on Monday, July 17 with “Hold”. Barclays Capital maintained it with “Equal-Weight” rating and $65 target in Friday, September 9 report. The rating was downgraded by PiperJaffray on Monday, March 20 to “Neutral”.

More notable recent Bristol-Myers Squibb Co (NYSE:BMY) news were published by: which released: “Bristol-Myers Squibb Combination Treatment Not At The End Of The Crossroad” on August 16, 2017, also with their article: “Bristol-Myers Squibb Is Primed for an Upside Breakout” published on August 31, 2017, published: “BRIEF-Bristol-Myers Squibb announces topline results” on August 15, 2017. The stock presently has an average rating of “Hold” and an average price target of $64.09. As per Friday, August 19, the company rating was maintained by UBS. The rating was downgraded by Topeka Capital Markets on Thursday, October 29 to “Hold”.

The company’s a year ago sales total was 4.92 Million. About shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since September 11, 2016 and is downtrending. On Wednesday, March 15 the insider Caldarella Joseph C sold $463,779. ANDREOTTI LAMBERTO also sold $1.81M worth of Bristol-Myers Squibb Co (NYSE:BMY) shares.

Thanks to the latest -0.35% decrease, it now trades at $62.62. Its down 0.03, from 0.98 in 2016Q3. It worsened, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. Blackrock holds 0.33% in Bristol-Myers Squibb Co (NYSE:BMY) or 4.01 million shares. Proshare Advsrs Limited Co reported 195,393 shares or 0.13% of all its holdings. Argent Capital Mgmt Limited Liability Company stated it has 7,958 shares or 0.02% of all its holdings.

Duncker Streett & Company Inc increased its stake in Bristol Myers Squibb Co (BMY) by 10.47% based on its latest 2016Q4 regulatory filing with the SEC. Massmutual Trust Communication Fsb Adv invested in 29,066 shares. Bath Savings Tru owns 0.28% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 15,773 shares. Eaton Vance reported 3.68 million shares. Salem Invest Counselors holds 93,749 shares or 0.63% of its portfolio. BKS Advisors LLC now owns 12,690 shares of the biopharmaceutical company’s stock worth $684,000 after buying an additional 2,410 shares in the last quarter. Cornerstone Invest Ptnrs Ltd Liability Corp reported 0.02% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). First Mercantile Trust holds 6,412 shares. Prentiss Smith And accumulated 1,442 shares or 0.05% of the stock. BMO Capital Markets maintained Bristol-Myers Squibb Co (NYSE:BMY) on Wednesday, April 5 with “Market Perform” rating. Thompson Rubinstein Mngmt Incorporated Or has 9,600 shares for 0.21% of their portfolio. Moreover, Swiss Commercial Bank has 0.43% invested in Bristol-Myers Squibb Co (NYSE:BMY).

Boston Family Office Llc increased Fiserv (NASDAQ:FISV) stake by 4,075 shares to 10,530 valued at $1.12 million in 2016Q4. Ishares Barclays 1 (SHY) was reduced too.

Weber Alan W holds 2.28% of its portfolio in Information Services Group, Inc. for 1.04 million shares. Hislop Colin sold $742,000 worth of Versartis Inc (NASDAQ:VSAR) on Tuesday, April 4. The insider Malik Shahzad sold 483,670 shares worth $8.76M. Hap Trading Limited Liability Company accumulated 137,270 shares. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. Therefore 89% are positive. On Monday, September 21 the stock rating was maintained by Canaccord Genuity with “Buy”. The firm earned “Equal-Weight” rating on Friday, August 5 by Morgan Stanley. The firm has “Hold” rating by Cowen & Co given on Monday, August 14. The firm earned “Overweight” rating on Thursday, July 13 by KeyBanc Capital Markets. The firm has “Buy” rating by Citigroup given on Thursday, August 11. (NASDAQ:AAPL). Brandywine Global Mngmt has invested 2.86% in Apple Inc. Jefferies has “Buy” rating and $6300 target. The rating was maintained by Jefferies with “Hold” on Tuesday, March 15. Canaccord Genuity maintained Versartis Inc (NASDAQ:VSAR) rating on Friday, May 26.

Investors sentiment increased to 1.22 in Q4 2016. Its down 0.03, from 0.98 in 2016Q3. It dropped, as 11 investors sold VSAR shares while 11 reduced holdings. 49 funds opened positions while 110 raised stakes. Bnp Paribas Arbitrage Sa stated it has 594 shares or 0% of all its holdings. 390,729 are held by Teachers Retirement Systems Of The State Of Kentucky. Grand Jean Cap Mngmt Inc has invested 4.56% of its portfolio in Apple Inc. Moreover, Tower Research Lc (Trc) has 0% invested in Versartis Inc (NASDAQ:VSAR). (NASDAQ:AAPL). Zweig invested in 87,268 shares or 0.73% of the stock. Bokf Na invested in 102,895 shares or 0.24% of the stock. Royal Natl Bank Of Canada has 0% invested in Versartis Inc (NASDAQ:VSAR).

Leave a Reply

Your email address will not be published. Required fields are marked *